Transtympanic dexamethasone application in Meniere's disease: An alternative treatment for intractable vertigo

Journal of Laryngology and Otology

Volumn 113, Issue 3, 1999, Pages 217-221

  Sennaroǧlu, Levent ^a,b   Dini, Farzin Mottaghian ^a   Sennaroǧlu, Gonca ^a   Gursel, Bulent ^a   Ozkan, Soner ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Meniere's disease; Steroids; Transtympanic dexamethasone; Vertigo

Indexed keywords

ACETAZOLAMIDE; BETAHISTINE; DEXAMETHASONE; ONADRON; STEROID; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; EARDRUM; FEMALE; HEARING ACUITY; HUMAN; MALE; MENIERE DISEASE; NERVE TRANSECTION; TOPICAL DRUG ADMINISTRATION; TYMPANOSTOMY TUBE; VERTIGO; VESTIBULAR NERVE;

EID: 0033049375     PISSN: 00222151     EISSN: None     Source Type: Journal    
DOI: 10.1017/s0022215100143610     Document Type: Article

References (17)

1. Brookes, G. B. (1986) Circulating immune complexes in Ménière's disease. Archives of Otolaryngology - Head and Neck Surgery 112: 536-540.
2. Danckwardt-Lilliestrom, N., Friberg, U., Kinnetors, A. (1997) Endolymphatic sacitis in a case of active Ménière's disease. A TEM histopathological investigation. Annals of Otology, Rhinology and Laryngology 106(3): 190-198.
3. Gutierrez, F., Moreno, P. M., Sainz, M. (1994) Relationship between immune complex and total hemolytic complement in endolymphatic hydrops. Laryngoscope 104: 1495-1498.
4. Itoh, A., Sakata, E. (1991) Treatment of vestibular disorders. Acta Otolaryngologica (Stockh) 481: 617-623.
5. Kimura, R. S., Hutta, J. (1997) Inhibition of experimentally induced endolymphatic hydrops by middle ear ventilation. European Archives of Otorhinolaryngology 254: 213-218.
6. Lohuis, P. J., ten Cate, W. J., Patterson, K. E. (1990) Modulation of rat stria vascularis in the absence of circulating adrenocorticosteroids. Acta Otolaryngologica (Stockh) 110: 348-356.
7. Montandon, P., Guillemin, P., Hausler, R. (1988) Prevention of vertigo in Ménière's syndrome by means of transtympanic ventilation tubes. ORL 50: 377-381.
8. Nadel, D. M. (1996) The use of systemic steroids in otolaryngology. Ear, Nose and Throat Journal 75: 502-516.
9. Pearson, B., Brackmann, D. E. (1985) Committee on hearing and equilibrium guidelines for reporting treatment results in Ménière's disease. Otolaryngology - Heart and Neck Surgery 96: 83-95.
10. Rarey, K. E., Lohuis, P. J. F. M., ten Cate, W. J. F. (1991) Response of stria vascularis to corticosteroids. Laryngoscope 101: 1081-1084.
11. Shea, J. J. (1993) Classification of Ménière's disease. American Journal of Otology 4: 224-229.
12. Shea, J. J., Ge, X. (1996) Dexamethasone perfusion of the labyrinth plus intravenous dexamethasone for Ménière's disease. Otolaryngologic Clinics of North America 29: 353-358.
13. Silverstein, H., Choo, D., Rosenberg, S., Kuhn, J. (1996) Intratympanic steroid treatment of inner ear disease and tinnitus (Preliminary report). Ear, Nose and Throat Journal 75: 468-488.
14. Suzuki, M., Kitahara, M. (1992) Immunologic abnormality in Ménière's disease. Otolaryngology - Head and Neck Surgery 107: 57-62.
15. Tumarkin, A. (1966) Thoughts on the treatment of labyrinthopathy. Journal of Laryngology and Otology 80: 1041-1053.
16. Yamanobe, S., Harris, J. P. (1993) Inner ear specific antibodies. Laryngoscope 103: 319-325.
17. Yoo, T. J. (1984) Etiopathogenesis of Ménière's disease. A hypothesis. Annals of Otology, Rhinology and Laryngology (Suppl 113) 93: 6-12.